X0306 4 2020-06-05 false 0001689813 Biohaven Pharmaceutical Holding Co Ltd. BHVN 0001329505 Bailey Gregory C/O BIOHAVEN PHARMACEUTICALS, INC. 215 CHURCH STREET NEW HAVEN CT 06510 true false false false Common Shares 2020-06-05 4 M false 212500.00 0.61 A 2800101.00 D Common Shares 2020-06-05 4 M false 150000.00 5.60 A 2950101.00 D Common Shares 2020-06-05 4 M false 37700.00 9.29 A 2987801.00 D Common Shares 2020-06-05 4 M false 20000.00 10.82 A 3007801.00 D Common Shares 2020-06-05 4 M false 18000.00 28.76 A 3025801.00 D Common Shares 2020-06-05 4 F false 30143.00 68.15 D 2995658.00 D Stock Option (Right to Buy) 28.76 2020-06-05 4 M false 18000.00 0.00 D 2028-04-30 Common Shares 18000.00 0.00 D Stock Option (Right to Buy) 10.82 2020-06-05 4 M false 20000.00 0.00 D 2027-04-05 Common Shares 20000.00 0.00 D Stock Option (right to buy) 9.29 2020-06-05 4 M false 37700.00 0.00 D 2026-12-14 Common Shares 37700.00 0.00 D Stock Option (Right to Buy) 5.60 2020-06-05 4 M false 150000.00 0.00 D 2025-10-22 Common Shares 150000.00 0.00 D Stock Option (Right to Buy) 0.61 2020-06-05 4 M false 212500.00 0.00 D 2024-11-25 Common Shares 212500.00 0.00 D No shares were sold - these shares were withheld by the Issuer to satisfy the option exercise price. The shares subject to this stock option vested in full on May 1, 2019. The shares underlying this option vested as to 25% of the shares on April 6, 2017, with the remainder vesting in 3 equal installments on the first, second and third anniversaries of the grant date, subject to the reporting person's continued service as of each applicable vesting date. The shares underlying this option vested as to 25% of the shares on December 15, 2016, with the remainder vesting in 3 equal installments on the first, second and third anniversaries of the grant date, subject to the reporting person's continued service as of each applicable vesting date. The shares underlying this option vested as to 25% of the shares on October 23, 2015, with the remainder vesting in 3 equal installments on the first, second and third anniversaries of the grant date, subject to the reporting person's continued service as of each applicable vesting date. The shares underlying this option vested as to 25% of the shares on November 26, 2014, with the remainder vesting in 3 equal installments on the first, second and third anniversaries of the grant date, subject to the reporting person's continued service as of each applicable vesting date. /s/ Jim Engelhart, Attorney-in-Fact 2020-06-08